Letters Non-publication of large randomised clinical trials Authors’ reply to van Lent and Out BMJ 2013; 347 doi: https://doi.org/10.1136/bmj.f7588 (Published 23 December 2013) Cite this as: BMJ 2013;347:f7588 Article Related content Metrics Responses Peer review Related articles Letter Effect of funding source on publication bias is not so clear cut Published: 23 December 2013; BMJ 347 doi:10.1136/bmj.f7582 See more Cancer drugs remain FDA approved despite lack of benefit, study finds BMJ December 06, 2016, 355 i6568; DOI: https://doi.org/10.1136/bmj.i6568 Johnson & Johnson is ordered to pay $1bn over faulty hip implants BMJ December 06, 2016, 355 i6551; DOI: https://doi.org/10.1136/bmj.i6551 Bill to boost medical research funding and speed drug approval passes US house BMJ December 01, 2016, 355 i6498; DOI: https://doi.org/10.1136/bmj.i6498 Trial of novel leukaemia drug is stopped for second time after two more deaths BMJ November 25, 2016, 355 i6376; DOI: https://doi.org/10.1136/bmj.i6376 Promise of new Alzheimer’s drug is dashed after lack of evidence BMJ November 24, 2016, 355 i6362; DOI: https://doi.org/10.1136/bmj.i6362
